Evidence map›Paper›PMID 30513935›Full record

ArticleInternational journal of molecular sciences2018

Differential Metabolic Responses to Adipose Atrophy Associated with Cancer Cachexia and Caloric Restriction in Rats and the Effect of Rikkunshito in Cancer Cachexia.

Yuka Sudo, Hiroki Otsuka, Ryota Miyakawa, Akifumi Goto, Yohei Kashiwase, Kiyoshi Terawaki, Kanako Miyano, Yuto Hirao, Kanari Taki, Ryoma Tagawa and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Cancer Cachexia and Related Metabolic Dysfunction.International journal of molecular sciences · 2020
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yuka SudoLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. yukafeatkoro@me.com.
Hiroki OtsukaLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. hirohtsuka@yahoo.co.jp.
Ryota MiyakawaLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. mykwryt.0518@gmail.com.
Akifumi GotoLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. s2kaki@yahoo.co.jp.
Yohei KashiwaseLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. yohei090109@yahoo.co.jp.
Kiyoshi TerawakiDivision of Cancer Pathophysiology, National Cancer Research Institute, Tokyo 104-0045, Japan. terawaki_kiyoshi@mail.tsumura.co.jp.
Kanako MiyanoDivision of Cancer Pathophysiology, National Cancer Research Institute, Tokyo 104-0045, Japan. kmiyano@ncc.go.jp.
Yuto HiraoLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. 3B15077@ed.tus.ac.jp.
Kanari TakiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. 3B18558@ed.tus.ac.jp.
Ryoma TagawaLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. tagawar@med.kobe-u.ac.jp.
Masaki KobayashiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. kobayashim@rs.tus.ac.jp.ORCID 0000-0002-0985-0322
Naoyuki OkitaTranslational Research Center, Research Institute of Science and Technology, Tokyo University of Science, Chiba 278-8510, Japan. nokita7@rs.tusy.ac.jp.
Yasuhito UezonoTranslational Research Center, Research Institute of Science and Technology, Tokyo University of Science, Chiba 278-8510, Japan. yuezono@ncc.go.jp.ORCID 0000-0003-1208-1453
Yoshikazu HigamiLaboratory of Molecular Pathology and Metabolic Disease, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba 278-8510, Japan. higami@rs.noda.tus.ac.jp.ORCID 0000-0003-1381-0777
Tokyo University of Science · JPTsumura Research Institute (Japan) · JP

Funding

Ministry of Health, Labour and Welfare H22-General-035
6 · The paper itself

Abstract

Despite the similar phenotypes, including weight loss, reduction of food intake, and lower adiposity, associated with caloric restriction (CR) and cancer cachexia (CC), CC is a progressive wasting syndrome, while mild CR improves whole body metabolism. In the present study, we compared adipose metabolic changes in a novel rat model of CC, mild CR (70% of the food intake of control rats, which is similar to the food consumption of CC rats), and severe CR (30% of the food intake of controls). We show that CC and severe CR are associated with much smaller adipocytes with significantly lower mitochondrial DNA content; but, that mild CR is not. CC and both mild and severe CR similarly upregulated proteins involved in lipolysis. CC also downregulated proteins involved in fatty acid biosynthesis, but mild CR upregulated these. These findings suggest that CC might impair de novo fatty acid biosynthesis and reduce mitochondrial biogenesis, similar to severe CR. We also found that rikkunshito, a traditional Japanese herbal medicine, does not ameliorate the enhanced lipolysis and mitochondrial impairment, but rather, rescues de novo fatty acid biosynthesis, suggesting that rikkunshito administration might have partially similar effects to mild CR.

Indexed as

Caloric RestrictionAdipocytesAdipose TissueAnimalsAtrophyCachexiaCell SizeDNA, MitochondrialDrugs, Chinese HerbalLipid MetabolismMaleMitochondriaNeoplasmsRats, NudeRats, WistarRNA, MessengerDNA, MitochondrialDrugs, Chinese Herballiu-jun-zi-tangRNA, Messengercaloric restrictioncancer cachexiarikkunshitosterol regulatory element-binding transcription factor 1c

Identifiers

PMID30513935
PMCPMC6321026
OpenAlexW2903230957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.